However, scholars who study semiglutide have not been able to find out exactly how the drug helps the kidneys. The researchers said there could be several mechanisms, including reducing inflammation of the kidneys, but more research is needed. Earlier in March, the U.S. Food and Drug Administration approved Wigobi for the purpose of reducing the risk of cardiovascular disease. Novo Nordisk said, "We will apply to the FDA to add that Ozempic can be used to reduce chronic kidney disease or complications in patients with type 2 diabetes."
Another study on efficacy has come out.
Watching these news, perhaps Wigobi is a panacea.
However, it doesn't seem clear yet whether there are any unknown side effects.
If there are more unknown effects,
It will also be possible to have unknown side effects.
Anyway, it's a great medicine.